Chonluten caps #60

The respiratory system is a set of structures that allow you to capture oxygen and remove carbon dioxide formed by internal respiration. The central organ is the lungs located on both sides of the heart. Lung diseases contribute to the development of pathological processes leading to a decrease in oxygen in the blood. This leads to a decrease in lung volume and the development of respiratory failure, leading to disability, significantly reducing the quality of life. To normalize and correct pathological changes in the lungs resulting from various diseases, a respiratory organ bioregulator - Chonluten was developed.

Chonluten is a peptide complex containing amino acids that contribute to the normalization of the function and cells of the lungs and mucous membrane of the bronchi. Clinical studies have established the effectiveness of Chonluten in the comprehensive prevention and treatment of patients with impaired lung and bronchial functions in acute and chronic respiratory diseases of an infectious and non-infectious origin, as well as for maintaining respiratory function in elderly and senile people. It was found that the course use of Chonluten, in addition to conventional therapy in patients with respiratory failure and lung damage, helped to improve well-being, reduce the frequency of coughing and suffocation attacks, reduce the amount of sputum being separated, and increase physical performance. Positive dynamics was noted in the form of a decrease in the number of wheezing, as well as a decrease in sputum production, which reflected the general tendency to reduce the inflammatory manifestations of the disease.

The use of Chonluten among athletes of the highest category in the process of preparing for competitions allowed to increase aerobic power and oxygen pulse, and increase respiratory reserve. Which led not only to an increase in physical performance compared to the initial level, but also preserved it until the end of the sports season. As a result of studies, it was shown that Chonluten has the ability to stimulate the functional activity of the main cellular elements of lung tissue, to reduce the level of spontaneous cell death. Thus, the drug has a trophic and stabilizing effect on the tissue of the lung and bronchi, improves its function.

Chonluten is well tolerated by patients, with no side effects, complications, contraindications and drug dependence.

Recommended by

    chronic respiratory failure,
    chronic cardiopulmonary failure,
    after pneumonia
    consequences of prolonged mechanical ventilation,
    respiratory distress syndrome
    pulmonary tuberculosis in remission,
    chest injuries
    burns of the upper respiratory tract,
    consequences of toxic lung injuries, including carbon monoxide poisoning,
    intense sports
    to maintain the function of the respiratory system in the elderly and senile.

Composition

peptide complex AC-7- (glycine, glutamic acid, aspartic acid). Excipients: microcrystalline cellulose (E460), beet sugar, lactose, starch, tween-80. As an additional source of peptides.

Release form: 60 capsules on 0,2 g.

Mode of application

Adults take 1-2 capsules 1-2 times a day on an empty stomach 30 minutes before eating. Duration of admission is 10-30 days. It is advisable to repeat the course after 4-6 months.